Vertex Pharmaceuticals
VRTX
#171
Rank
NZ$230.22 B
Marketcap
NZ$908.91
Share price
1.36%
Change (1 day)
25.39%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): NZ$8.76 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$12.58 Billion. In 2025 the company made an earning of NZ$8.59 Billion, an increase over its 2024 earnings that were of NZ$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$8.76 B2.01%
2025 NZ$8.59 B1627.59%
2024 NZ$0.49 B-93.69%
2023 NZ$7.88 B3.19%
2022 NZ$7.63 B53.56%
2021 NZ$4.97 B-12.06%
2020 NZ$5.65 B118.45%
2019 NZ$2.58 B120.64%
2018 NZ$1.17 B1473.64%
2017 NZ$74.59 M197.6%
2016 NZ$25.06 M-102.97%
2015 -NZ$0.85 Billion-28.46%
2014 -NZ$1.18 Billion-51.5%
2013 -NZ$2.44 Billion-30584.68%
2012 NZ$7.97 M-95.47%
2011 NZ$0.17 B
2009 -NZ$1.06 Billion
2007 -NZ$0.74 Billion83.1%
2006 -NZ$0.41 Billion59.02%
2005 -NZ$0.26 Billion3.28%
2004 -NZ$0.25 Billion-38.16%
2003 -NZ$0.4 Billion
2000 -NZ$67.79 Million-20.38%
1999 -NZ$85.14 Million31.62%
1998 -NZ$64.69 Million91.05%
1997 -NZ$33.86 Million-36.24%
1996 -NZ$53.11 Million12.45%
1995 -NZ$47.23 Million27.4%
1994 -NZ$37.07 Million-1833.33%
1993 NZ$2.13 M-112.12%
1992 -NZ$17.65 Million175%
1991 -NZ$6.42 Million-12.2%
1990 -NZ$7.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$15.50 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$3.49 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.22 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$89.48 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA